2021年6月最新SCI期刊列表已更新,欢迎查询使用! 如果您对期刊系统有任何需求或者问题,欢迎
反馈给我们。 ![]() |
基本信息 | 登录收藏 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | LANCET ONCOLOGY LANCET ONCOL LetPub评分 9.8
51人评分
我要评分
声誉 10.0 影响力 9.7 速度 9.3 | |||||||||||||||||
期刊ISSN | 1470-2045 | 微信扫码收藏此期刊 | ||||||||||||||||
E-ISSN | 1474-5488 | |||||||||||||||||
2020-2021最新IF (数据来源于搜索引擎) | 登录后查看IF和趋势图 | |||||||||||||||||
2020-2021自引率 | 1.20%登录查看自引率趋势图 | |||||||||||||||||
h-index | 274 | |||||||||||||||||
CiteScore |
| |||||||||||||||||
期刊简介 | The Lancet Oncology publishes interesting and informative reviews on any topic connected with oncology, and considers any original research contribution that advocates change in, or illuminates, oncological clinical practice. Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal. All papers should be written to be clearly understandable to the journal’s readers in a wide range of specialties and countries. | |||||||||||||||||
期刊官方网站 | http://www.thelancet.com/journals/lanonc/issue/current | |||||||||||||||||
期刊投稿网址 | https://www.editorialmanager.com/THELANCETONCOLOGY | |||||||||||||||||
是否OA开放访问 | No | |||||||||||||||||
通讯方式 | ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, USA, NY, 10010-1710 | |||||||||||||||||
出版商 | Lancet Publishing Group | |||||||||||||||||
涉及的研究方向 | 医学-肿瘤学 | |||||||||||||||||
出版国家或地区 | UNITED STATES | |||||||||||||||||
出版语言 | English | |||||||||||||||||
出版周期 | Monthly | |||||||||||||||||
出版年份 | 2000 | |||||||||||||||||
年文章数 | 159登录查看年文章数趋势图 | |||||||||||||||||
Gold OA文章占比 | 5.98% | |||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 78.62% | |||||||||||||||||
WOS期刊SCI分区 ( 2020-2021年最新版) | WOS分区等级:1区
| |||||||||||||||||
中科院《国际期刊预警 名单(试行)》名单 | 2021年12月发布的2021版:不在预警名单中 2021年01月发布的2020版:不在预警名单中 | |||||||||||||||||
中科院SCI期刊分区 ( 2021年12月最新基础版) | 登录查看中科院JCR分区趋势图
| |||||||||||||||||
中科院SCI期刊分区 ( 2021年12月最新升级版) |
| |||||||||||||||||
中科院SCI期刊分区 ( 2020年12月旧的升级版) |
| |||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) Scopus (CiteScore) | |||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1470-2045%5BISSN%5D | |||||||||||||||||
平均审稿速度 | 网友分享经验: 一般,3-8周 | |||||||||||||||||
平均录用比例 | 网友分享经验: 极难 | |||||||||||||||||
期刊常用信息链接 |
|
|
|
|
登录查看自引率趋势图 |
登录查看中科院JCR分区趋势图 |
登录查看年文章数趋势图 |
中国学者近期发表的论文 | |
1. | Deep convolutional neural network models for the diagnosis of thyroid cancer – Authors' reply Author: Xiangchun Li, Sheng Zhang, Qiang Zhang, Xi Wei, Ming Gao, Wei Zhang, Kexin Chen Journal: LANCET ONCOLOGY, 2019, Vol.20, e131, DOI:10.1016/s1470-2045(19)30083-x DOI |
2. | Pazopanib in the treatment of advanced solitary fibrous tumour Author: Chao Tu, Xiaolei Ren, Jieyu He, Chenghao Zhang, Zhihong Li Journal: LANCET ONCOLOGY, 2019, Vol.20, e127, DOI:10.1016/s1470-2045(19)30030-0 DOI |
3. | Deep convolutional neural network models for the diagnosis of thyroid cancer Author: Dan Hu, Feng Peng, Wenquan Niu Journal: LANCET ONCOLOGY, 2019, Vol.20, e129, DOI:10.1016/s1470-2045(19)30025-7 DOI |
4. | DPYD genotype-guided dose individualisation of fluoropyrimidine therapy: who and how? Author: Ka On Lam, Chi Chung Tong, Victor Ho Fun Lee, Mai Yee Luk, Ching Wan Lam Journal: LANCET ONCOLOGY, 2019, Vol.20, e66, DOI:10.1016/s1470-2045(18)30867-2 DOI |
5. | Challenges in anticancer drug R&D in China Author: Shen Zhao, Cheng Lv, Jifang Gong, Fang Wenfeng, Xichun Hu, Yi Ba, Chen Xiaoyuan, Yang Zhimin, Lin Shen, Li Zhang Journal: LANCET ONCOLOGY, 2019, Vol.20, 183-186, DOI:10.1016/s1470-2045(18)30865-9 DOI |
6. | One-view breast tomosynthesis vs two-view mammography: a methodological issue Author: Xiang Fang, Weili Kong, Jianqing Qiu, Zeping Yu, Hong Duan Journal: LANCET ONCOLOGY, 2019, Vol.20, e6, DOI:10.1016/s1470-2045(18)30811-8 DOI |
7. | Lung squamous carcinoma involving the lip and cheek Author: Binjie Yan, Fang Wu, Nong Yang, Yongchang Zhang Journal: LANCET ONCOLOGY, 2018, Vol.19, e726, DOI:10.1016/s1470-2045(18)30441-8 DOI |
8. | Maternal use of hormonal contraception and risk of childhood leukaemia Author: Yubin Cao, Chunjie Li, Longjiang Li Journal: LANCET ONCOLOGY, 2018, Vol.19, e657, DOI:10.1016/s1470-2045(18)30810-6 DOI |
9. | Common analgesics and ovarian cancer prognosis Author: Jianzheng Jie, Wenquan Niu Journal: LANCET ONCOLOGY, 2018, Vol.19, e505, DOI:10.1016/s1470-2045(18)30572-2 DOI |
10. | Follow-up surveillance of Wilms' tumour Author: Guohui Fan, Qian Zhang Journal: LANCET ONCOLOGY, 2018, Vol.19, e501, DOI:10.1016/s1470-2045(18)30529-1 DOI |
|
|
首页 上一页 1 下一页 尾页 (去 | |
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分: | |
同领域作者分享投稿经验:共3条 (包含回复) |
我来分享 |
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2022 中国: LetPub上海分公司 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960
增值电信业务经营许可证:沪B2-20211595
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦2103室
United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451